Skip to content
Review Open access

Cholesterol dysregulation and microglial NLRP3 inflammasome activation after ischemic stroke: implications for neuroinflammation and functional recovery

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 53 references
Medicine

TL;DR

Current evidence supports a proposed, evidence-stratified framework in which cholesterol-related lipid stress, microglial state, inflammasome susceptibility, and tissue repair partially converge rather than forming a single validated linear causal axis.

Abstract

Secondary neuroinflammation is an important determinant of tissue injury, repair, and neurological recovery after ischemic stroke, yet the lipid-metabolic environment in which this response develops remains incompletely integrated into current mechanistic models. This narrative review synthesizes PubMed-indexed, peer-reviewed literature published between 2010 and 2026 on post-stroke cholesterol metabolism, microglial lipid handling, NLRP3 inflammasome signaling, immunometabolic remodeling, therapeutic intervention, and recovery-related outcomes. Ischemic injury substantially remodels the local lipid environment through neuronal membrane disruption, myelin breakdown, oxidative lipid modification, altered cholesterol turnover, and blood–brain barrier dysfunction, generating a heterogeneous pool of free cholesterol, cholesteryl esters, lipid droplets, cholesterol crystals, oxysterols, and oxidized lipids. Stroke-specific studies increasingly support the emergence of cholesterol- and lipid-loaded microglial states and show that microglial lipid-processing capacity, including TREM2- and SREBP2-related mechanisms, can influence inflammatory and reparative responses. However, the causal connection between cholesterol dysregulation and NLRP3 activation remains only partly resolved. Direct stroke evidence supports the coexistence of microglial cholesterol overload and NLRP3-associated inflammatory changes, whereas detailed mechanisms involving cholesterol crystal-induced lysosomal injury, metabolic remodeling, and intracellular lipid stress remain partly dependent on cross-model evidence. Oxysterol effects are context dependent, and recent cholesterol-mobilization experiments identify mitochondrial DNA leakage–STING signaling as an alternative, more directly validated downstream pathway. Post-stroke microglia are also functionally heterogeneous, with distinct populations contributing to debris clearance, white matter repair, and neurological recovery. Therapeutically, systemic lipid management should be distinguished from experimental strategies that modify brain cholesterol handling or suppress inflammasome-associated inflammation, and no integrated cholesterol–microglia–NLRP3 treatment strategy has yet been clinically validated. Collectively, current evidence supports a proposed, evidence-stratified framework in which cholesterol-related lipid stress, microglial state, inflammasome susceptibility, and tissue repair partially converge rather than forming a single validated linear causal axis.

Read PDF

Similar papers

Review Open access Oct 2026

Microglial lipid metabolism in perioperative neurocognitive risk: aging-related priming, organelle crosstalk, and lipid-redox injury

Abstract Perioperative neurocognitive disorders (PND) are clinically important complications in older surgical patients, but broad neuroinflammatory models do not fully explain age-related susceptibility or failed recovery. Aging alters microglial surveillance, phagocytosis, mitochondrial function, lipid handling, and...

Ding-Liang Cai, Xin-Jie Ke, Fang Luo et al. · 0 citations
Review Open access Oct 2026

Microglial lipid metabolic reprogramming in neuroinflammation.

ABSTRACT Abnormal microglial activation is a key driver of the neuroinflammatory cascade. Recent studies have shown that lipid metabolic reprogramming regulates microglial polarization and inflammatory function in a spatiotemporally specific manner. The acute phase is characterized primarily by adaptive lipid droplet f...

Yan Liu, Ying Huang, Yang Liao et al. · 0 citations
Review Open access Sep 2026

Lipid signaling and foam cell formation in atherosclerosis and spinal cord injury

Macrophages and microglia serve as both “scavengers” and “immune sentinels” to maintain tissue homeostasis. However, when the lipid load exceeds their processing capacity, these cells transform into foam cells, thereby driving chronic inflammation and impairing tissue repair. Despite their distinct organ systems, ather...

Gui-Na Tan, Xiao-Xin Wang, Jing Chen et al. · 0 citations
Review Open access 2026

The Microglial Lipid-Immune Axis in Brain Aging: Adaptive Lipid Handling and Metabolic Dysfunction in Lipid-Droplet-Accumulating Microglia

Microglia in the aging brain process lipids released during membrane and myelin turnover. Lipid droplets can buffer this demand, but lipid retention also accompanies defective phagocytosis and inflammatory responses. This review critically compares the substrates, perturbations, and functional endpoints underlying thes...

Unknown authors · 0 citations
Review Open access Oct 2026

Dynamic Functional Remodeling of Microglia and Monocyte-Derived Macrophages After Ischemic Stroke: A Narrative Review of Traditional Chinese Medicine Mechanisms and Translational Perspectives

Ischemic stroke elicits a dynamic and heterogeneous myeloid response involving brain-resident microglia and recruited monocyte-derived macrophages, whose functional programs are shaped by lineage, spatial context, metabolic state, and disease stage. Traditional Chinese medicine (TCM) has been widely investigated for is...

Xin-Yu Li, Cui-Cui Chang, Yu-Jie Kuai et al. · 0 citations
Review Open access Sep 2026

From microglial activation to neurovascular remodeling: Chitinases as integrative mediators in ischemic stroke – A narrative review

Ischemic stroke is characterized by a complex interplay between neuroinflammation, oxidative stress, and vascular dysfunction, ultimately leading to disruption of the neurovascular unit and impaired tissue recovery. While microglial activation is a central driver of postischemic inflammation, increasing evidence indi...

Lucia Malaguarnera · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.